The NIH-sponsored Training Program in Investigative Rheumatology, begun at Yale in 1976, has the philosophy that a portion of both M.D. and Ph.D. biomedical scientists should be trained in an environment that focuses upon mechanisms of rheumatologic and immunologic diseases, and approaches to the bedside investigation of these illnesses. This belief is grounded in the notion that the challenges involved in understanding such clinical problems require a cohort of investigators whose knowledge and training enable them to span the gaps between basic biology and clinical rheumatology and immunology. Hence, the goals of this program are to attract individuals who are interested in learning about fundamental mechanisms of disease and the applications of this knowledge. The program is focused upon clinical investigation in the rheumatic diseases, with an emphasis on providing training in immunology, microbiology, cellular and molecular biology, and the clinical sciences as applied to the understanding and therapy of rheumatic diseases;is comprised of both physician and Ph.D. trainees;and has for its training faculty a collaborative group of 36 physician and basic scientists from the Section of Rheumatology and other Sections in the Department of Medicine, and basic investigators from the Department of Immunobiology. The quality, cohesiveness, and diverse skills of these mentors, along with the skills and the desire of our trainees, are the most important requisites for success of our program. Five trainees (M.D. and Ph.D.) per year are currently supported, with an increase to six requested in this renewal. This request is based upon the continued success of the program and the number of high quality applicants and mentors. M.D. trainees typically perform clinical work in the first year of their fellowship (supported by clinical funds), and then enter research training. The combination of both M.D. and Ph.D. fellows gives the M.D. fellows a much better research experience, and it exposes the Ph.D. fellows to opportunities to apply their skills to rheumatologic problems. Fellows supported by this Training Grant receive didactic as well as interactive instruction in biology, clinical investigation, and ethical issues in science. This program provides trainees with the foundation in basic and clinical science that will enable them to bridge the differences between basic research and clinical approaches to understanding rheumatic diseases.
The understanding and treatment of the rheumatic diseases requires a cadre of highly trained physician and Ph.D. scientists. The goals of this program are to train the next generation of such individuals, by seeking highly qualified trainees, and providing them with intense exposure to other highly qualified trainees with a wide range of backgrounds and offering them mentorship from a high quality and broad-based training faculty. This philosophy has been highly successful in producing investigators devoted to dissecting the mechanisms of rheumatologic and immunologic diseases, and approaches to the bedside investigation of these illnesses, and it is anticipated that it will remain so with the training plan and mentorship that is provided by this training program.
|Hsiao, Betty; Binder-Finnema, Pauline; Benjamin Nowell, W et al. (2018) Preference phenotypes can be used to support shared decision-making at point-of-care for patients with rheumatoid arthritis: A proof of concept study. Arthritis Care Res (Hoboken) :|
|Wang, Andrew; Huen, Sarah C; Luan, Harding H et al. (2018) Glucose metabolism mediates disease tolerance in cerebral malaria. Proc Natl Acad Sci U S A 115:11042-11047|
|Hsiao, Betty; Bhalla, Sonal; Mattocks, Kristin et al. (2018) Understanding the Factors That Influence Risk Tolerance Among Minority Women: A Qualitative Study. Arthritis Care Res (Hoboken) 70:1637-1645|
|Kim, Sang Taek; Choi, Jin-Young; Lainez, Begona et al. (2018) Human Extrafollicular CD4+ Th Cells Help Memory B Cells Produce Igs. J Immunol 201:1359-1372|
|Herndler-Brandstetter, Dietmar; Shan, Liang; Yao, Yi et al. (2017) Humanized mouse model supports development, function, and tissue residency of human natural killer cells. Proc Natl Acad Sci U S A 114:E9626-E9634|
|Hsiao, Betty; Fraenkel, Liana (2017) Incorporating the patient's perspective in outcomes research. Curr Opin Rheumatol 29:144-149|
|Choi, Jin-Young; Seth, Abhinav; Kashgarian, Michael et al. (2017) Disruption of Pathogenic Cellular Networks by IL-21 Blockade Leads to Disease Amelioration in Murine Lupus. J Immunol 198:2578-2588|
|Weinstein, Jason S; Herman, Edward I; Lainez, Begoña et al. (2016) TFH cells progressively differentiate to regulate the germinal center response. Nat Immunol 17:1197-1205|
|Hsieh, Evelyn; Fraenkel, Liana; Han, Yang et al. (2016) Longitudinal increase in vitamin D binding protein levels after initiation of tenofovir/lamivudine/efavirenz among individuals with HIV. AIDS 30:1935-42|
|Wang, Andrew; Huen, Sarah C; Luan, Harding H et al. (2016) Opposing Effects of Fasting Metabolism on Tissue Tolerance in Bacterial and Viral Inflammation. Cell 166:1512-1525.e12|
Showing the most recent 10 out of 56 publications